A Study of GenSci098 in Subjects With Active Thyroid Eye Disease

Clinical trial NCT06569758 · RECRUITING

Trial details

NCT number: NCT06569758
Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Safety Tolerability GenSci098 Thyroid Eye Disease (TED)

Start date: 2024-09-24
Primary completion: 2027-09-02
Enrollment: 76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.